Source:http://linkedlifedata.com/resource/pubmed/id/19797820
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-10-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0971-5916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
130
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
202-4
|
pubmed:meshHeading |
pubmed-meshheading:19797820-Animals,
pubmed-meshheading:19797820-Biomarkers, Pharmacological,
pubmed-meshheading:19797820-Clinical Trials, Phase I as Topic,
pubmed-meshheading:19797820-Drug Design,
pubmed-meshheading:19797820-Europe,
pubmed-meshheading:19797820-Humans,
pubmed-meshheading:19797820-Pharmaceutical Preparations,
pubmed-meshheading:19797820-United States,
pubmed-meshheading:19797820-United States Food and Drug Administration
|
pubmed:year |
2009
|
pubmed:articleTitle |
Human microdosing; a boon or a bane?
|
pubmed:publicationType |
Letter
|